![](/documents/10803/2546915/mch-opal-app-thumbnail.jpg/c04fae30-2a4e-a3cc-bb93-45d8e9488b2c?t=1617209224259)
The Montreal Children’s Hospital launches the bilingual Opal patient portal app
In a Quebec first, a child’s medical info is just a click away
![](/documents/10803/1980864/health+impact-inactivity-benefit-adults-astronauts-thumbnail.jpg/54eb1b93-b1c6-6be4-c1d4-d15b2be46a96?t=1614181199702)
Understanding the health impact of inactivity for the benefit of older adults and astronauts
A study using bedrest as an analog to microgravity will provide data for eight Canadian research projects
![](/documents/10803/1974906/dr-lucy-gilbert-top-women-of-influence-canada-2021-thumbnail.jpg/2f8a695b-8b60-71f2-998c-7ea48abdca45?t=1612968736697)
Dr. Lucy Gilbert named to the Top Women of Influence™ in Canada for 2021
Dr. Gilbert's work on testing varian and endometrial cancers early is saving countless lives
![](/documents/10803/1980864/when-is-dead-really-dead-thumbnail.jpg/5f1d54b8-7f06-2a1d-629f-18f190173024?t=1612965393313)
When is dead really dead?
Dr. Sam Shemie leads the death prediction and physiology after removal of therapy study (DePPaRT study)
![](/documents/10803/1980864/ri-researchers-support-efforts-covid-19-thumbnail.jpg/0180de8d-51f3-6058-0d06-024767f255b1?t=1612549746711)
RI-MUHC researchers support Canada’s efforts to address the COVID-19 pandemic
Drs. Emily McDonald and Todd C. Lee are part of the Canadian Network of COVID-19 Clinical Trials Networks...
![](/documents/10803/1700924/two-studies-confirm-efficiency-saliva-tests-covid-19-thumbnail.jpg/ff2b5d70-7e43-8891-4dc3-90ce7043aeae?t=1610734434944)
Two studies confirm efficiency of saliva tests for COVID-19
Testing is the cornerstone of the fight against COVID-19, and a test that can be self-administered would greatly increase the options for case...
![](/documents/10803/1700924/could-antidepressant-slow-covid-19-progression_thumbnail.jpg/fd01f535-2198-d47a-e108-6e171af5add9?t=1611345703746)
Could an antidepressant slow COVID-19 progression?
RI-MUHC researchers launch a clinical trial of fluvoxamine, a drug that has already proven efficient in reducing lung injury in animal studies and...
![](/documents/10803/1700924/clip-at-ri-muhc-announces-first-member-company-thumbnail.jpg/3888398a-def6-97d2-2975-2635f6f57ba1?t=1609789779351)
Clinical Innovation Platform at the RI-MUHC announces first member company
Health tech accelerator welcomes AltPAP Innovation to its new state-of-the-art facility
![](/documents/10803/1448868/ri-muhc-leads-new-clinical-trial-covid-19-thumbnail.jpg/04c62459-4f2e-7baa-f12b-4a5ec6e7d8a4?t=1608056347673)
The RI-MUHC leads new clinical trial of COVID-19 treatment for hospitalized patients
Phase 2 study tests LAU-7b, a Canadian drug with dual antiviral and inflammation-controlling effects
![](/documents/10803/1241665/ron-gottesman-quebecs-royal-college-mentor-thumbnail.jpg/b758a83f-5732-0b00-7bb2-0eac4b814456?t=1607366644871)
Dr. Ron Gottesman is Quebec’s Royal College Mentor of the Year
Mentorship applies to the whole team, whole person